BLK enters the back half of August carrying real momentum — up 14.5% over the past month to $1,173.73 — while the analyst community has shifted decisively more positive following Q2 results, making the valuation debate the most live question heading into October earnings.
The Street's direction of travel after the July 15 Q2 print was unusually uniform. JP Morgan upgraded the stock to Overweight from Neutral, lifting its target from $1,165 to $1,364. Morgan Stanley, UBS, Barclays, BofA, Evercore, and KBW all raised targets simultaneously, with the cluster spanning $1,260 to $1,488. The mean consensus target now stands at roughly $1,314, implying around 12% upside from current levels — respectable but narrower than it was a month ago given how much the stock has already moved. Evercore's Glenn Schorr added a further nudge this week, raising to $1,260, signalling the Street remains broadly constructive even after the rally. Bulls point to $13.5 trillion in AUM, organic base fee growth running at 6-7% and ahead of management's 2030 targets, and the expected HPS contribution to fee rates. Bears counter that G&A expenses are projected to grow more than 13% this year, operating margin estimates have been revised down, and the shift toward lower-margin passive products remains a structural drag that no amount of alternatives growth fully offsets. Factor scores add nuance: forward earnings momentum ranks in the 97th percentile across the universe, and the analyst recommendation differential ranks at the 92nd — both unusually strong readings. EV/EBIT, however, ranks at the 28th percentile, suggesting the market is paying up on earnings growth expectations rather than on asset value.
Positioning looks almost entirely uncrowded. Short interest sits at just 1.4% of the free float — around 2.17 million shares — and has drifted up only modestly over the past month, rising roughly 6.7% in absolute terms without any meaningful directional signal. Borrowing is essentially free at 0.24%, down sharply from elevated levels a month ago. Availability is at maximum capacity — the lending pool is barely tapped, with roughly 154 million shares available against a short position of barely 2 million. There is no borrow squeeze, no short-side pressure, and no sign that bears are building conviction into the rally. Options confirm the same picture: the put/call ratio at 0.96 is sitting almost exactly on its 20-day average of 0.96, with a z-score near zero. The 52-week PCR high of 2.07 reflects moments of genuine fear this stock has seen; right now, options traders are neutral. The short score of 31.1 is low and stable, consistent with a stock where bearish positioning is minimal.
One ownership detail is worth noting. Wellington Management added 2.19 million shares in the quarter to June 30, a substantial build that makes it a top-ten holder. Temasek, by contrast, trimmed 135,000 shares over the same period. On the insider side, CEO Larry Fink sold around 1,905 shares on July 16 at $1,081, shortly after the earnings pop. CLO Christopher Meade sold a combined ~18,000 shares the same day for roughly $20 million. These are not unusual sizes relative to total holdings at a company of this market standing, and the trades appear to have been pre-planned. President Rob Kapito sold roughly 8,700 shares in late April at around $1,057. The aggregate 90-day insider net in shares is modestly positive at just under 63,000 shares — a reading that owes more to equity compensation mechanics than to any fresh directional signal.
The next earnings date is October 16. The Q2 print produced a 6% one-day gain. The Q1 print before it saw the stock fall 3%. What to watch between now and then is whether BLK can hold the $1,100–$1,175 range as the gap between the current price and the consensus target narrows, and whether fee rate data from the broader asset management sector — close peers IVZ and KKR both gained around 3-11% on the week — corroborates or complicates the growth-fee narrative that drove the July upgrade wave.
See the live data behind this article on ORTEX.
Open BLK on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
